Novel consent process for research in dying patients unable to give consent
Objectives To develop a process of advance consent to enable research to be undertaken in patients in the terminal phase. Design Feasibility study of an advance consent process to support a randomised controlled trial of two antimuscarinic drugs (hyoscine hydrobromide and glycopyrronium bromide) in...
I tiakina i:
| I whakaputaina i: | BMJ |
|---|---|
| Ngā kaituhi matua: | , |
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
BMJ Publishing Group
2003
|
| Ngā marau: | |
| Urunga tuihono: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC166125/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12881261/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/bmj.327.7408.198 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|